Search For "dr reddy"
Equity indices trade higher, banks and financials lead
Updated : 5 years, 2 months ago IST
Mumbai (Maharashtra) [India], May 21 (ANI): Equity benchmark indices traded firm during early hours on Friday with banking and financial stocks leading the rally.
Read More
Prices of Sputnik V COVID-19 vaccine may drop after local manufacturing be
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], May 20 (ANI): The pricing of the Sputnik V COVID-19 vaccine, currently capped at Rs 995 per dose, is expected to come down once local manufacturing of the vaccine begins, according to a company spokesperson from Dr Reddy's Laboratories.
Read More
DRDO's anti-COVID 2-DG drug an add-on, not substitute for other medicines:
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], May 17 (ANI): The DRDO's new anti-COVID drug 2DG is an add-on and not a substitute for any of the drugs that are used to treat coronavirus patients, said Deepak Sapra, the CEO of Pharmaceutical Services and API, Dr. Reddy's labs.
Read More
Dr Reddy's labs, Apollo hospitals launch pilot programme for administering
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], May 17 (ANI): Dr Reddy's labs collaborated with Apollo hospitals and launched a pilot programme for administering the Russian COVID-19 vaccine Sputnik V vaccine on Monday.
Read More
Another Indian company, Shilpa Medicare, joins efforts to ramp up manufact
Updated : 5 years, 2 months ago IST
Moscow [Russia], May 17 (ANI): In a bid to speed up India's COVID-19 vaccination efforts, another Indian company, Shilpa Medicare has joined efforts to ramp up the manufacturing capacity of the Sputnik V vaccine.
Read More
COVID-19: 60,000 doses of Sputnik V vaccine reach India in second batch
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], May 16 (ANI): The second consignment of the SputnikV vaccine that arrive in India on Sunday contained 60,000 doses, Dr Reddy's Laboratory informed.
Read More
First jab of Sputnik V COVID-19 vaccine administered; to cost around Rs 1,
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], May 14 (ANI): With the Sputnik V COVID-19 vaccine receiving clearance in India, Deepak Sapra, Global Head of Custom Pharma Services at Dr Reddy's Laboratories received the first jab of the vaccine in Hyderabad.
Read More
Dr Reddy's posts Q4 profit of Rs 554 crore, revenues at Rs 4,728 crore
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], May 14 (ANI): Dr Reddy's Laboratories on Friday reported a consolidated net profit of Rs 554 crore for the quarter ended March, down 28 per cent from Rs 764 crore in the same period of the previous fiscal.
Read More
Dr Reddy's announces launch of Sputnik vaccine in Indian market
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], May 14 (ANI): Dr Reddy's Laboratories said on Friday that the first consignment of imported doses of Sputnik V vaccine that landed in India on May 1 received regulatory clearance from the Central Drugs Laboratory at Kasauli in Himachal Pradesh on May 13.
Read More
Lilly signs 3 more pacts to accelerate availability of baricitinib for Cov
Updated : 5 years, 2 months ago IST
New Delhi [India], May 13 (ANI): Eli Lilly and Company said on Thursday it has issued additional royalty-free, non-exclusive voluntary licenses to Dr Reddy's Ltd, MSN Laboratories and Torrent Pharmaceuticals who will collaborate to accelerate and expand the availability of baricitinib in Ind
Read More
Dr Reddy's enters into licensing agreement with Eli Lilly for COVID-19 tre
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], May 12 (ANI): Dr Reddy's Laboratories on Tuesday said that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialization of the drug baricitinib, in India.
Read More
Sensex jumps 296 points, pharma stocks surge
Updated : 5 years, 2 months ago IST
Mumbai (Maharashtra) [India], May 10 (ANI): Equity benchmark indices were range-bound on Monday but closed in the green on the back of RBI's liquidity measures and indications of robust corporate earnings.
Read More